$417 Million is the total value of SECTOR GAMMA AS's 31 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 42.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LLY | Sell | LILLY ELI & CO | $46,320,000 | +12.8% | 786,947 | -2.2% | 11.11% | +0.3% |
| BAX | Buy | BAXTER INTL INC | $42,875,000 | +77.3% | 582,700 | +67.6% | 10.28% | +57.6% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $27,186,000 | -12.8% | 2,010,800 | -22.5% | 6.52% | -22.5% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $23,260,000 | +63.0% | 313,600 | +44.5% | 5.58% | +44.9% |
| ABBV | New | ABBVIE INC | $22,791,000 | – | 443,400 | +100.0% | 5.46% | – |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $20,608,000 | +72.7% | 390,000 | +31.0% | 4.94% | +53.5% |
| JNJ | Sell | JOHNSON & JOHNSON | $18,443,000 | -2.5% | 187,750 | -9.1% | 4.42% | -13.4% |
| PKI | Buy | PERKINELMER INC | $16,040,000 | +37.4% | 355,960 | +25.7% | 3.85% | +22.1% |
| DGX | Buy | QUEST DIAGNOSTICS INC | $15,009,000 | +83.1% | 259,128 | +69.2% | 3.60% | +62.7% |
| CAH | Sell | CARDINAL HEALTH INC | $14,395,000 | -27.1% | 205,700 | -30.4% | 3.45% | -35.2% |
| THOR | Buy | THORATEC CORP | $13,869,000 | +40.3% | 387,300 | +43.4% | 3.32% | +24.7% |
| IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $12,653,000 | +46.9% | 1,026,991 | +38.4% | 3.03% | +30.6% |
| WCG | New | WELLCARE HEALTH PLANS INC | $12,367,000 | – | 194,700 | +100.0% | 2.96% | – |
| CBST | Sell | CUBIST PHARMACEUTICALS INC | $12,171,000 | +0.4% | 166,390 | -5.5% | 2.92% | -10.8% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $11,954,000 | +12.0% | 145,800 | +2.9% | 2.87% | -0.5% |
| A | Sell | AGILENT TECHNOLOGIES INC | $11,743,000 | -27.4% | 210,000 | -25.8% | 2.82% | -35.5% |
| LPNT | Sell | LIFEPOINT HOSPITALS INC | $11,068,000 | -3.0% | 202,900 | -6.1% | 2.65% | -13.8% |
| RMD | Buy | RESMED INC | $9,876,000 | +38.9% | 221,000 | +46.4% | 2.37% | +23.5% |
| ACOR | Buy | ACORDA THERAPEUTICS INC | $9,504,000 | +183.0% | 250,700 | +118.0% | 2.28% | +151.5% |
| 5100PS | New | VOLCANO CORPORATION | $9,380,000 | – | 475,900 | +100.0% | 2.25% | – |
| PDCO | New | PATTERSON COMPANIES INC | $9,194,000 | – | 220,165 | +100.0% | 2.20% | – |
| AUXL | Sell | AUXILIUM PHARMACEUTICALS INC | $7,720,000 | -19.5% | 284,020 | -38.6% | 1.85% | -28.4% |
| BIO | Buy | BIO RAD LABS INCcl a | $7,674,000 | +6.7% | 59,900 | +2.9% | 1.84% | -5.2% |
| THC | Buy | TENET HEALTHCARE CORP | $7,449,000 | +123.9% | 174,000 | +120.3% | 1.79% | +98.9% |
| ESRX | Sell | EXPRESS SCRIPTS INC | $6,510,000 | -36.9% | 86,700 | -40.9% | 1.56% | -43.9% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $5,878,000 | +33.6% | 62,510 | +60.7% | 1.41% | +18.7% |
| IART | Buy | INTEGRA LIFESCIENCES HLDGS C | $4,185,000 | +23.6% | 91,000 | +28.2% | 1.00% | +9.7% |
| MDCO | Sell | MEDICINES CO | $3,625,000 | -67.4% | 127,550 | -55.7% | 0.87% | -71.0% |
| CTRX | New | CATAMARAN CORP | $2,686,000 | – | 60,000 | +100.0% | 0.64% | – |
| SPPI | SPECTRUM PHARMACEUTICALS INC | $392,000 | -11.5% | 50,000 | 0.0% | 0.09% | -21.7% | |
| VVUS | New | VIVUS INC | $238,000 | – | 40,000 | +100.0% | 0.06% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -136,800 | -100.0% | -0.65% | – |
| OMI | Exit | OWENS & MINOR INC NEW | $0 | – | -80,084 | -100.0% | -0.79% | – |
| HNT | Exit | HEALTH NET INC | $0 | – | -145,000 | -100.0% | -1.16% | – |
| AGN | Exit | ALLERGAN INC | $0 | – | -45,000 | -100.0% | -1.35% | – |
| BIIB | Exit | BIOGEN IDEC INC | $0 | – | -20,000 | -100.0% | -1.51% | – |
| STJ | Exit | ST JUDE MED INC | $0 | – | -106,000 | -100.0% | -1.77% | – |
| MASI | Exit | MASIMO CORP | $0 | – | -243,150 | -100.0% | -1.92% | – |
| FRX | Exit | FOREST LABS INC | $0 | – | -440,349 | -100.0% | -7.13% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.